Search Results 141-150 of 16195 for pharmacogenetics
Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...
Mayo Clinic researchers are connecting genomics and environmental factors to improve health outcomes.
But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment ...
Learn about how our experts use testing, genetic counseling and treatments to help people with a family history of heart disease at risk of heart attacks.
While some would like to drape the mantle "The father of pharmacogenomics" on Richard Weinshilboum, M.D., the scientist parries: "The only thing that I'm father ...
Ames' laboratory provided me with the training essential to understand the pharmacology and pharmacogenetics of drug metabolism.” — Matthew Goetz, M.D.. In ...
About this study. The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of ...
In January 2017, the Cytogenetics Laboratory and Molecular Genetics Laboratory combined to form one laboratory now known as the Genomics Laboratory. To reflect ...
It is well-established that DNA methylation plays an important role in control of gene expression, which in turn can influence phenotypic variance and ...
About this study. The purpose of this study is to provide descriptive information on patients with hereditary hemochromatosis, including their predominant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.